Cargando…

Axillary Lymphadenopathy Associated With COVID-19 Vaccination: Updates and Recommendations

Lymphadenopathy (LAD) associated with vaccination has been documented as complicating the evaluation of metastatic malignancy. In the past this was a limited finding, primarily documented in association with smallpox and H1N1 vaccination.The advent of the novel mRNA vaccine for COVID-19 in December...

Descripción completa

Detalles Bibliográficos
Autor principal: Schwaner, Sandra L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association for Radiologic & Imaging Nursing. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388443/
https://www.ncbi.nlm.nih.gov/pubmed/35999889
http://dx.doi.org/10.1016/j.jradnu.2022.08.006
_version_ 1784770226965970944
author Schwaner, Sandra L.
author_facet Schwaner, Sandra L.
author_sort Schwaner, Sandra L.
collection PubMed
description Lymphadenopathy (LAD) associated with vaccination has been documented as complicating the evaluation of metastatic malignancy. In the past this was a limited finding, primarily documented in association with smallpox and H1N1 vaccination.The advent of the novel mRNA vaccine for COVID-19 in December of 2021, and subsequent large scale vaccination effort, has resulted in a marked increase in the identification of LAD associated with vaccination. Because axillary LAD is a concerning sign of metastatic disease in breast cancer, identifying the difference between benign inflammatory reaction and concerning LAD and avoiding unnecessary additional imaging and biopsy is an essential skill. This article describes the current literature, recommendations for follow-up, and interventions to improve diagnostics.
format Online
Article
Text
id pubmed-9388443
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Association for Radiologic & Imaging Nursing. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-93884432022-08-19 Axillary Lymphadenopathy Associated With COVID-19 Vaccination: Updates and Recommendations Schwaner, Sandra L. J Radiol Nurs Article Lymphadenopathy (LAD) associated with vaccination has been documented as complicating the evaluation of metastatic malignancy. In the past this was a limited finding, primarily documented in association with smallpox and H1N1 vaccination.The advent of the novel mRNA vaccine for COVID-19 in December of 2021, and subsequent large scale vaccination effort, has resulted in a marked increase in the identification of LAD associated with vaccination. Because axillary LAD is a concerning sign of metastatic disease in breast cancer, identifying the difference between benign inflammatory reaction and concerning LAD and avoiding unnecessary additional imaging and biopsy is an essential skill. This article describes the current literature, recommendations for follow-up, and interventions to improve diagnostics. Association for Radiologic & Imaging Nursing. Published by Elsevier Inc. 2022-12 2022-08-19 /pmc/articles/PMC9388443/ /pubmed/35999889 http://dx.doi.org/10.1016/j.jradnu.2022.08.006 Text en © 2022 Association for Radiologic & Imaging Nursing. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Schwaner, Sandra L.
Axillary Lymphadenopathy Associated With COVID-19 Vaccination: Updates and Recommendations
title Axillary Lymphadenopathy Associated With COVID-19 Vaccination: Updates and Recommendations
title_full Axillary Lymphadenopathy Associated With COVID-19 Vaccination: Updates and Recommendations
title_fullStr Axillary Lymphadenopathy Associated With COVID-19 Vaccination: Updates and Recommendations
title_full_unstemmed Axillary Lymphadenopathy Associated With COVID-19 Vaccination: Updates and Recommendations
title_short Axillary Lymphadenopathy Associated With COVID-19 Vaccination: Updates and Recommendations
title_sort axillary lymphadenopathy associated with covid-19 vaccination: updates and recommendations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388443/
https://www.ncbi.nlm.nih.gov/pubmed/35999889
http://dx.doi.org/10.1016/j.jradnu.2022.08.006
work_keys_str_mv AT schwanersandral axillarylymphadenopathyassociatedwithcovid19vaccinationupdatesandrecommendations